INanoBio
INanoBio is a startup based out of Scottsdale, AZ and Menlo Park, CA. The company's mission is to develop high-accuracy early-stage disease diagnostics using its transformative nano-biotechnology platforms and machine learning. INanoBio envisions developing preemptive disease diagnostics by extracting systems-scale information from complex disease biology, identifying and detecting disease-specific molecular biomarker signatures at prodromal or pre-symptomatic stages, enabling early intervention and cure.
Last updated on
About INanoBio
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$3MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
ScottsdaleState
ArizonaCountry
United StatesINanoBio
Find your buyer within INanoBio